Motomiya, Y. (2024) “Serum Levels of the C-terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients with Hemodialysis Undergoing Treatment with a Proline Hydroxylase Domain (PHD) Inhibitor”, Journal of Clinical Nephrology, 8(3), pp. 132–137. doi: 10.29328/journal.jcn.1001141.